Störungen des Wasser- und Elektrolythaushalts

Schlüsselwörter

Hyponatriämie - Tolvaptan - Desmopressin - Natriumkanäle - Durstregulation

Keywords

hyponatremia - tolvaptan - desmopressin - natrium channels - regulation of thirst

Literatur

• 1 Berl T, Quittnat-Pelletier F, Verbalis J G. et al . Oral tolvaptan is safe and effective in chronic hyponatremia.  J Am Soc Nephrol. 2010;  21 705-712
• 2 Berl T, Rastegar A. A patient with severe hyponatremia and hypokalemia: osmotic demyelination following potassium repletion.  Am J Kidney Dis. 2010;  55 742-748
• 3 Einhorn L M, Zhan M, Hsu V D. et al . The frequency of hyperkalemia and its significance in chronic kidney disease.  Arch Intern Med. 2009;  169 1156-1162
• 4 Hiyama T Y, Matsuda S, Fujikawa A. et al . Autoimmunity to the sodium-level sensor in the brain causes essential hypernatremia.  Neuron. 2010;  66 508-522
• 5 Konstam M A, Gheorghiade M, Burnett J C Jr. et al . Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.  JAMA. 2007;  297 1319-1331
• 6 Korgaonkar S, Tilea A, Gillespie B W. et al . Serum potassium and outcomes in CKD: insights from the RRI-CKD cohort study.  Clin J Am Soc Nephrol. 2010;  5 762-769
• 7 Perianayagam A, Sterns R H, Silver S M. et al . DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia.  Clin J Am Soc Nephrol. 2008;  3 331-336
• 8 Schrier R W, Gross P, Gheorghiade M. et al . Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia.  N Engl J Med. 2006;  355 2099-2112
• 9 Suzuki H, Sugimura Y, Iwama S. et al . Minocycline prevents osmotic demyelination syndrome by inhibiting the activation of microglia.  J Am Soc Nephrol. 2010;  21 2090-2098
• 10 Tian W, Fu Y, Garcia-Elias A. et al . A loss-of-function nonsynonymous polymorphism in the osmoregulatory TRPV4 gene is associated with human hyponatremia.  Proc Natl Acad Sci U S A. 2009;  106 14034-14039
• 11 Wang C J, Lin Y N, Huang S W. et al . Low dose oral desmopressin for nocturnal polyuria in patients with benign prostatic hyperplasia: a double-blind, placebo controlled, randomized study.  J Urol. 2011;  185 219-223